Guo‐He Lin
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- CAR-T cell therapy research
- Inflammatory Biomarkers in Disease Prognosis
- Cancer Cells and Metastasis
Papers in
- Oncology 24
- Cancer Immunotherapy and Biomarkers 6
- Lung Cancer Research Studies 6
- Peptidase Inhibition and Analysis 5
- Pancreatic and Hepatic Oncology Research 4
- HER2/EGFR in Cancer Research 3
-
- Lung Cancer Treatments and Mutations 5
- Co-authors
- Shengping Li (5 shared papers)Bi‐Cheng Wang (29 shared papers)Yize Mao (5 shared papers)Shuhong Li (3 shared papers)Xiang‐Ming Lao (3 shared papers)Zeyu Shuang (4 shared papers)Jianlin Chen (4 shared papers)Jun Wang (4 shared papers)
- Journals
- Medicine (8 papers)Journal of Oncology (4 papers)Annals of Palliative Medicine (2 papers)Frontiers in Immunology (2 papers)BMC Cancer (2 papers)
- Partner nations
- ChinaUnited StatesSwitzerland
In The Last Decade
Guo‐He Lin
35 papers receiving 422 citations
Peers
Comparison fields: 5 of 64
- Oncology 266
- Cancer Research 82
- Immunology 103
- Otorhinolaryngology 17
- Surgery 107
Countries citing papers authored by Guo‐He Lin
This map shows the geographic impact of Guo‐He Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guo‐He Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guo‐He Lin more than expected).
Fields of papers citing papers by Guo‐He Lin
This network shows the impact of papers produced by Guo‐He Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guo‐He Lin. The network helps show where Guo‐He Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Guo‐He Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 86 | |
| 2 | 2016 | 69 | |
| 3 | 2012 | 64 | |
| 4 | 2018 | 38 | |
| 5 | 2020 | 19 | |
| 6 | 2020 | 16 | |
| 7 | 2010 | 14 | |
| 8 | 2018 | 12 | |
| 9 | 2020 | 11 | |
| 10 | 2016 | 10 | |
| 11 | 2020 | 9 | |
| 12 | 2020 | 9 | |
| 13 | 2021 | 8 | |
| 14 | 2022 | 7 | |
| 15 | 2021 | 7 | |
| 16 | 2023 | 6 | |
| 17 | 2020 | 6 | |
| 18 | 2022 | 5 | |
| 19 | 2024 | 4 | |
| 20 | 2022 | 3 |
About Guo‐He Lin
Guo‐He Lin is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Pathology and Forensic Medicine and Epidemiology, having authored 37 papers that have together received 427 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (6 papers), Lung Cancer Research Studies (6 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers), Peptidase Inhibition and Analysis (5 papers), Lung Cancer Treatments and Mutations (5 papers), Pancreatic and Hepatic Oncology Research (4 papers), HER2/EGFR in Cancer Research (3 papers) and Head and Neck Cancer Studies (3 papers). The work is most often cited by research in Oncology (266 citations), Cancer Research (82 citations), Immunology (103 citations), Otorhinolaryngology (17 citations) and Surgery (107 citations). Guo‐He Lin has collaborated with scholars based in China, United States and Switzerland. Frequent co-authors include Shengping Li, Bi‐Cheng Wang, Yize Mao, Shuhong Li, Xiang‐Ming Lao, Zeyu Shuang, Jianlin Chen, Jun Wang, Limin Zheng and Jing Xu. Their work appears in journals such as Medicine, Journal of Oncology, Annals of Palliative Medicine, Frontiers in Immunology and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.